Hesperidin exhibits anti-cancer effects by inducing cell death in hepatocellular carcinoma HepG2 cells through caspase-independent pathways, primarily by activating the ERK1/2 pathway (Yumnam et al., 2014). The gene discussed is MAPK3; the disease is cancer.